NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/20/2022
Back to search
Official data from USPTO
RIBON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
12/23/2022
Trademark type
Word
Nice classes
5
Filing date
10/02/2019
Registration date
12/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2022
Last transaction
12/23/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/27/2022
First use in commerce
10/27/2022
Drawing code
4
Owner type
03
Owner location
Cambridge, MA, US
Examiner
LAPTER, ALAIN
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc.
Representatives
John V. Hobgood, Esquire WILMER CUTLER PICKERING HALE AND DORR LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in the diagnosis and treatment of oncologic diseases
Publications
History of USPTO decisions and trademark events.
47 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/20/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/12/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/09/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2022
GNRT
NON-FINAL ACTION E-MAILED
11/08/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/08/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/07/2022
IUAF
USE AMENDMENT FILED
10/31/2022
EISU
TEAS STATEMENT OF USE RECEIVED
10/31/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/20/2022
EX5G
SOU EXTENSION 5 GRANTED
10/19/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/19/2022
EXT5
SOU EXTENSION 5 FILED
10/11/2022
EEXT
SOU TEAS EXTENSION RECEIVED
10/11/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/14/2022
EX4G
SOU EXTENSION 4 GRANTED
04/12/2022
EXT4
SOU EXTENSION 4 FILED
04/12/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/12/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/08/2021
EX3G
SOU EXTENSION 3 GRANTED
10/06/2021
EXT3
SOU EXTENSION 3 FILED
10/06/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/06/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/10/2021
EX2G
SOU EXTENSION 2 GRANTED
04/08/2021
EXT2
SOU EXTENSION 2 FILED
04/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/08/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/13/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/13/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/13/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/13/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/09/2020
EX1G
SOU EXTENSION 1 GRANTED
10/07/2020
EXT1
SOU EXTENSION 1 FILED
10/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/07/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/18/2020
PUBO
PUBLISHED FOR OPPOSITION
02/18/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/29/2020
ALIE
ASSIGNED TO LIE
01/16/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/13/2020
DOCK
ASSIGNED TO EXAMINER
01/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2019
NWAP
NEW APPLICATION ENTERED
10/05/2019
Continuous trademark protection
Get notified about every new filing that threatens RIBON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.